Document is current

Any future updates will be listed below

Correction to: New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo

Crossref DOI link: https://doi.org/10.1007/s00262-024-03727-0

Published Online: 2024-07-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark